Medicxi unveils €500m fund for asset-centric biotechs [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
of growing concern at the state of the commercial landscape in Europe compared to the US. Medicxi, a self-ascribed European life sciences venture capital firm, has dubbed the fund Medicxi V, which will focus on an asset-centric investment model. Medicxi will use the €500m kitty to continue supporting drug hunters and entrepreneurs in creating asset-focused biotechnology companies. The firm will also consider assisting existing companies no matter their stage of development, providing they offer strong asset value. This marks Medicxi's sixth fund raise with these having totalled over €2bn. The company has a strong history of backing companies that have gone onto have successful exits. There have even been three notable acquisitions since the last fundraise. The most recent was Vicebio, a UK vaccine developer acquired by Sanofi for $1.6bn in July 2025 as the drugmaker tightened its vaccine pipeline. Eli Lilly spent $1.9bn to acquire Versanis Bio in July 2023, while Genmab acquir
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Press Release: Sanofi completes acquisition of VicebioGlobeNewswire
- Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Deutsche Bank Maintains a Buy Rating on Sanofi (SNY) [Yahoo! Finance]Yahoo! Finance
- Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation [Yahoo! Finance]Yahoo! Finance
- AI won't cure cancer, says Sanofi CEO [CNBC]CNBC
SNY
Sec Filings
- 12/3/25 - Form 6-K
- 11/18/25 - Form 6-K
- 11/14/25 - Form SCHEDULE
- SNY's page on the SEC website